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ABSTRAK 
TAJUK 
Penilaian tentang kebolehpercayaan dan  kesahihan PedsQLTM 3.0 Modul Kardiak 
versi Bahasa  Melayu. 
OBJEKTIF 
Untuk menghasilkan PedsQLTM 3.0 Modul Kardiak versi bahasa  Melayu yang boleh 
dipercayai dan sahih. 
TATACARA 
Ini merupakan kajian keratan rentas melibatkan kanak-kanak yang menghidapi 
penyakit jantung kongenital di antara umur 5-18 tahun dan ibubapa yang mana 
anaknya berumur 2-18 tahun. Sejumlah 528 peserta terlibat dalam kajian ini adalah 
yang hadir di klinik pakar kanak-kanak kardiologi dan klinik ekokardiografi di 
Hospital Raja Perempuan Zainab II dan Hospital Universiti Sains Malaysia. Tatacara 
yang digunakan termasuklah penterjemahan ke hadapan dan ke belakang, kesahihan 
isimuka dan kandungan  soalan PedsQLTM 3.0 Modul Kardiak versi bahasa Melayu. 
KEPUTUSAN 
Kajian ini menyokong kebolehpercayaan dan kesahihan PedsQLTM 3.0 Modul 
Kardiak dalam menilai tahap kesihatan kualiti hidup kanak-kanak yang menghidapi 
penyakit jantung di masa hadapan. 
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KESIMPULAN 
PedsQLTM 3.0 Modul Kardiak versi Bahasa Melayu ini  terbukti akan 
kebolehpercayaan dan kesahihannya. Soalan  PedsQLTM 3.0 Modul Kardiak  ini 
sangat  berguna untuk menilai tahap kualiti hidup pesakit yang menghidapi masalah 
jantung. 
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ABSTRACT 
TITLE 
Assessment of reliability and validity of the Malay version PedsQLTM 3.0 Cardiac 
Module 
OBJECTIVE 
To produce a reliable and validated Malay version of the PedsQLTM 3.0 Cardiac 
Module. 
METHODS 
This is a cross sectional study involving children with congenital heart disease 
between 5-17 years old and parent of children with congenital heart disease aged 2-
18 years old. A total of 528 participants were enrolled into this study when they 
presented to the pediatric cardiology clinic and echocardiography clinic at Hospital 
Raja Perempuan Zainab II and Hospital Universiti Sains Malaysia. The methods used 
including forward and backward translation, face and content validation of Malay 
version of the PedsQLTM 3.0 Cardiac Module questionnaires. 
RESULT 
Most of  27 items in PedsQLTM 3.0 Cardiac Module questionnaires showed 
satisfactory internal consistency with Cronbach Alpha exceeding 0.7 and good 
correlation with  intraclass correlation coefficient 0.76-0.98. There were no missing 
data. 
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CONCLUSION 
The result generally supports reliability and validity of   Malay version PedsQLTM 
3.0 Cardiac Module in assessing HRQOL among children with heart disease. 
ABSTRACT 
 
ASSESSMENT OF RELIABILITY AND VALIDITY OF THE 
MALAY VERSION PedsQLTM 3.0 CARDIAC MODULE 
 
Dr Farohah Che Mat Zain 
MMed Paediatric 
 
Department of Paediatric 
School of Medicine, Universiti Sains Malaysia 
Health Campus, 16150 Kelantan, Malaysia 
 
Introduction: The improvement in medical and surgical treatment over the last 
decades has led to a dramatic increase in survival rates of patients with congenital 
heart disease (CHD). Hence, it is  a very important to focus on HRQOL among 
children with CHD. Up to date, there is no assessment tool in Bahasa Melayu to 
measure HRQOL among children with heart disease. The validated tool is available 
is in English and other languages. The PedsQLTM 3.0 Cardiac Module was chosen 
because it has been validated, developmentally appropriate for our subjects, disease 
specific, includes both self and proxy-report and covering a wider age group for 
 children 5-18 years old and parent-proxy age 2-18 years old, it can be conducted 
within 15 minutes, the questionnaires also multidimensional and had minimal 
missing data. 
 
Objective: To produce a reliable and validated Malay version of the PedsQLTM 3.0 
Cardiac Module. 
 
Patients and Methods: This is a cross sectional study involving children with CHD 
between 5-17 years old and parent of children with CHD aged 2-18 years old. A total 
of 528 participants were enrolled into this study when they presented to the pediatric 
cardiology clinic and echocardiography clinic at Hospital Raja Perempuan Zainab II 
and Hospital Universiti Sains Malaysia. The methods used including linguistic 
validations of Malay version of the PedsQLTM 3.0 Cardiac Module questionnaires. 
 
Results: Most of 27 items in Malay version PedsQLTM 3.0 Cardiac Module 
questionnaires showed satisfactory internal consistency with Cronbach Alpha 
exceeding 0.7 and good correlation with intraclass correlation coefficient 0.76-0.98. 
The validity also showed all the domains are significantly correlated among each 
other. There were no missing data. 
 
Conclusion: The result generally supports reliability and validity of   Malay version 
PedsQLTM 3.0 Cardiac Module in assessing HRQOL among children with congenital 
heart disease. 
 
Associate Prof Dr Ariffin Nasir (Supervisor) 
Associate Prof Dr Norsarwany Mohamad (Co-Supervisor) 
Prof Col (B) Dr. Wan Pauzi (Co-Supervisor) 
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1. INTRODUCTION 
According to National Institutes of Health (National heart, lung and blood institute, 
2011), Congenital heart disease (CHD) is defined as problems with the heart’s 
structure that are present at birth. The defects may  involved the interior wall, valves 
and vessels of the heart. There are several types of congenital heart disease that range 
from a simple lesion to the complex defects. Congenital heart disease is the most 
common type of birth defect (National heart, lung and blood institute, 2011).  
In Malaysia, there are many pediatric cardiology centres and Hospital Raja 
Perempuan Zainab II (HRPZ II) and Hospital Universiti Sains Malaysia (HUSM) are 
the tertiary centers in Kelantan. It is the regional centre of the east coast of peninsular 
Malaysia and received patients from the state of Kelantan and Terengganu.  
The global incidence of congenital heart disease is about 8/1000 live birth (Hoffman, 
1995). According to Malaysian Ministry of Health in 2007, they estimated about 
4000 to 5000 children were born with congenital heart disease yearly (Annual report 
Ministry of Health, 2007). There is no local data on the incidence of congenital heart 
disease in Kelantan. A total of 2073 congenital heart disease was detected in children 
born in the state of Johor from 2006-2012 with the prevalence of 5.5 per 1000 live 
birth (Mat Bah, 2014) as presented in table 1.1. The most common type of congenital 
heart disease in Johor is ventricular septal defect. The severity of congenital heart 
disease among 2073 Johorean patient, 891 (43%) was severe and 964 (46%) were 
mild lesions. Regarding the prognosis of Johorean patient, 28% required no 
intervention and 16% of the cardiac lesions close spontaneously and the overall 
mortality rate was 12.2% (Mat Bah, 2014). 
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In the last several decades, advances in the medical and surgical care has 
increasingly improve the survival of patient living with chronic conditions. Hence, it 
is also critical to focus on the effort to improve the quality of life for patient with 
chronic illness such as congenital heart disease.  
In Malaysia, no study has been undertaken to evaluate the quality of life in children 
with cardiac diseases. 
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Table 1.1 Epidemiology of Congenital Heart Disease in Johor from 2006 to 2012 
Diagnosis Number of 
patients 
Number of CHD in 
percentage (%) 
VSD 711 34.3 
PDA 392 18.9 
PS 204 9.8 
TOF 121 5.8 
ASD 112 5.4 
TGA 61 2.9 
AVSD 52 2.5 
COA 43 2.1 
Heterotaxia syndrome 36 1.7 
PAVSD 35 1.7 
PAIVS 32 1.5 
DORV 31 1.5 
Tricuspid atresia 30 1.4 
HLHS 25 1.2 
TAPVD 22 1.1 
PAVSD, MAPCAs 20 1.0 
Ebsteins anomaly 19 0.9 
Mitral atresia 18 0.9 
Unbalance AV canal 15 0.7 
Truncus arteriosus 14 0.7 
DILV 14 0.7 
Aortic stenosis 13 0.6 
Interrupted arch 11 0.5 
Vascular rings and slings 8 0.4 
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Table 1.1 Epidemiology of Congenital Heart Disease in Johor from 2006 to 2012  
(continue) 
ccTGA 8 0.4 
Pulmonary artery abnormality 6 0.3 
Coronary artery fistula 5 0.2 
Cor triatriatum 4 0.2 
ALCAPA 3 0.1 
AP window 2 0.1 
Mitral stenosis 1 0.0 
Single ventricle, other 1 0.0 
Hemitruncus 1 0.0 
AV discordant, VA concordant 1 0.0 
Partial anomalous venous connection 1 0.0 
Coronary artery anomalies, others 1 0.0 
Total 2073 100 
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2. LITERATURE REVIEW 
2.1 AETIOLOGY OF CONGENITAL HEART DISEASE 
The aetiology of congenital heart disease is known to be multi-factorial. These 
include genetic predisposition, infection, teratology and environmental stimuli. A 
family history of the heart disease in close relatives increases the chances of 
congenital heart disease in subsequent pregnancy. A mother with congenital heart 
disease has 6% risk of having an affected offspring while an affected father has a 2% 
risk. Study has shown that having a child with congenital heart disease confers a risk 
of 2 to 3% in subsequent pregnancy but having a child with hypoplastic left heart 
syndrome (HLHS) or having two or more children with congenital heart disease 
could increase the risk of congenital heart disease by 10% in a subsequent child  
(Yogen, Ying-Hui, Renu, 2014). 
Recently, the genetic factors are being recognized as playing an important role. They 
have identified single nucleotide polymorphisms and submicroscopic copy number 
abnormalities as having a role in the pathogenesis of congenital heart disease 
(Richards & Garg, 2010). This work has aided the discovery of an increasing number 
of monogenic causes of human cardiovascular malformations. 
 
2.2 SCREENING OF CONGENITAL HEART DISEASE 
The screening of congenital heart disease can be divided into the antenatal and 
postnatal screening. In the United Kingdom, any suspicion of congenital heart 
disease on screening or high risk factors in women warrants specialist fetal 
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echocardiography (Yogen et al., 2014). The indications for fetal echocardiography 
can be divided into three: 
A) Antenatal 
1. Fetal factors:  
• Suspected cardiac anomaly on ultrasound  
• Increased nuchal translucency thickness on ultrasound 
• Abnormal fetal karyotype such as trisomies (21, 18, 13), Turner 
syndrome, 22q11 deletion  
• Other congenital anomalies like an exomphalos and diaphragmatic 
hernia 
• Fetal hydrops  
• Fetal arrhythmia  
• Twin to twin transfusion syndrome  
2. Maternal factors:  
• Increased maternal risk for Down’s syndrome and other 
congenital defects (advanced maternal age or increased risk of 
Down’s syndrome on serum screening)  
• Maternal alcohol abuses  
• Maternal ingestion of teratogenic drugs (anticonvulsants, lithium, 
retinoic acid, amphetamines)  
• Maternal diseases (insulin-dependent diabetes mellitus, 
phenylketonuria, exposure to Rubella, Coxsackie or Parvovirus 
infection, maternal Ro/La antibodies)  
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3. Familial factors:  
• Family history of congenital heart diseases in the first-degree 
relative  
• Genetic syndromes 
 
B) Postnatal 
Globally, Pulse Oxymetry Screening (POS) postnatally is used currently as the 
method to screen ductal dependent congenital heart disease (Yogen et al., 2014). 
They reported POS was feasible, cost-effective, well-tolerated, simple, and 
acceptable to parents and clinical staff. These findings are substantial enough to meet 
the criteria for universal screening (Yogen et al., 2014). 
 
2.3 CLINICAL PRESENTATION OF CONGENITAL HEART DISEASE 
The signs and symptoms of congenital heart disease may be non-specific in infants 
or bigger children. The symptoms includes symptoms of cardiac failure, recurrent 
infection, failure to thrive, unwell infant, feeble or absent pulses (brachial or 
femoral), persistent cyanosis in the absence of respiratory distress or cyanotic 
episodes, low oxygen saturation (<95%), heart murmur, presence of dysmorphic 
features or other congenital anomalies, sudden death, presence of arrhythmias and 
heart failure. 
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2.4 PSYCHOSOCIAL IMPACTS OF CONGENITAL HEART DISEASE 
AMONG CHILDREN 
The improvement in medical and surgical treatment over the last decades has led to a 
dramatic increase in survival rates of patients with congenital heart disease. This 
resulted in the emergence of a growing population of children with congenital heart 
disease with or without surgical correction. Medical professionals managing these 
patients also have to deal concomitantly with their daily life issues.  
Physical activity is a major issue in children with congenital heart disease that has a 
significant impact on their daily activity as participation in sport and exercise 
capacity has a direct link with cardiac status and a variety of risks, such as 
arrhythmias or syncope. The majority of the parent limit their child from engaging in 
physical activity. Nowadays, it is widely recognized that physical activity has long-
term beneficial effects not only on the quality of life but also on long-term morbidity 
and overall mortality (Piepoli, Davos, Francis, 2004). Various studies were done to 
prove that exercise capacity differs significantly across the spectrum in congenital 
heart disease. It is important that the patient and their family are informed that 
exercise restriction is very rarely indicated. Obviously, safety is a major concern 
when prescribing exercise and athletic activities for children with cardiac disease, 
especially those with hypertrophic cardiomyopathy, coronary artery anomalies, 
Marfan syndrome and aortic valve disease, which have been associated with sudden 
cardiac death. 
The issue regarding traveling was frequently propped up and physicians are asked by 
patients with chronic heart disease, whether they could travel safely. Questions 
usually relate to commercial aircraft travel or visiting locations at higher altitude. 
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Patients with cyanotic congenital heart disease, like healthy people, experience a fall 
in arterial oxygen saturation of about 8% from baseline but tolerate this well without 
supplemental oxygen; they maintain adequate tissue oxygen delivery due to the 
chronic rightward shift in their oxyhemoglobin dissociation curve and to secondary 
erythrocytosis (Broberg, Uebing, Cuomo, Thein, Papadopoulos, & Gatzoulis, 2007). 
In these Broberg et al. (2007) study, patients with Eisenmenger syndrome report 
traveling frequently and safely on commercial airlines. 
The other problem faced by children with congenital heart disease is 
neuropsychological function including low intelligence, lack of attention or 
inadequate motor skill. In the study of Uzark, Jones, Burwinkle, & Varni, (2003), the 
mean verbal and performance IQ scores were in the high 80s and approximately 40% 
had scores less than 85, a full standard deviation below the population mean. 
Nevertheless, in some studies, the mean IQ score did not differ significantly from 
that of the general population. Clinical significant score on the hyperactivity scale 
was observed in the study by Shillingford, Glanzman, Ittenbach, Clancy, Gaynor, & 
Wernovsky, (2008) using the Behavior Assessment System for Children that was 3 
to 4 times more frequent among the congenital heart disease patients than in the 
standardization sample. 
There was an impact of missing school or being unable to attend fulltime because of 
treatment, outpatient appointments and fatigue (Birks, Sloper, Lewin & Parsons, 
2007). Another study by Larcombe, (1995) described the children with other chronic 
conditions has also shown that prolonged periods of absence from school raised the 
concerns about keeping up with work and maintaining relationships with peers. 
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In the study done by Van Rijen, Utens, Roos-Hesselink, Meijboom, Van Domburg, 
Roelandt, & Verhulst, (2003), there was the high proportion of patients with a history 
of special education. The main reason for attendance of special education includes 
frequent hospitalization. Additionally, the highest educational level completed was 
more often a lower level compared to the normal group (Van Rijen et al., 2003). 
The social functioning of the patient with congenital heart disease can be considered 
favourable. There were no significant differences were found in participation in 
leisure time activities, the congenital heart disease patients obtained similar 
involvement as compared to normal group of children. They also involved in 
outgoing and domestic activities (Van Rijen et al., 2003). In contrast, to another 
study by Utens, Verhulst, Erdman, Meijboom, Duivenvoorden, Bos, & Hess, (1994), 
which showed patient with congenital heart disease appeared to prefer handicrafts 
more often and to visit sports and watch television less often than did their normal 
peers group. 
 
2.5  QUALITY OF LIFE  
The quality of life can be described in various ways. World Health Organization 
(WHO) defined the quality of life as individual perception of their position in life in 
the context of the culture and value systems in which they live and in relation to their 
goals, expectations, standard and concerns (WHO, 1995). Whereby, health is defined 
as ‘a state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity’ (WHO, 1947).  
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Quality of life may be described as a child's ability to function in situational contexts 
of family, school, peer and derive personal satisfaction from doing so (Aaronson, 
1988). 
Some studies refer quality of life as life satisfaction meaning, well-being, happiness, 
health, functional status and adjustment (Ferrans & Powers, 1985). 
Assessment of quality of life of children is more complex. The complexity of 
assessing quality of life is due to the developmental differences in understanding the 
content measured. Children with congenital heart disease are at risk of multiple other 
problems such as physical, psychological, social, growth and educational 
achievement.  
 
2.6 FACTORS AFFECTING QUALITY OF LIFE IN CHILDREN WITH 
CONGENITAL HEART DISEASE  
There are numbers of factors that may affect the quality of life in children with 
congenital heart disease depending on their stages of growth. In infancy, they are 
totally dependent on their parents and as they enter early childhood, they have 
different needs such as relationships with other children and obtaining independence 
or knowledge (Nousi & Christou, 2010). 
Factors affecting quality of life in children with congenital heart disease are the 
following:  
1. Delay in physical growth, including the height and the weight, which vary 
depending on the type and severity of the disease. Children with cyanotic congenital 
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heart disease have the most pronounced delay in physical growth, which can be 
obvious from a very young age. 
2. The change in the body image in both the pre-operative and post-operative period 
experienced by children with congenital heart disease at all stages of physical growth 
especially school-going age. The large incision scar post-operatively may give rise to 
comments or questions in the child's environment, especially at the school. 
3. Children with congenital heart disease experience anxiety and depression due to 
the frequent hospitalization, daily medications and the limitations imposed by the 
disease itself. 
4. The social acceptance in the school environment is lacking. The physical 
impairment that these patients experience makes them unable to participate in school 
activities such as physical exercise. Usually, they have refrained from activities they 
used to enjoy before the onset of the disease, thus the feeling of loneliness, rejection, 
and social isolation, which makes social integration even more difficult. The 
overprotective behavior of the parents, who sometimes do not permit the children to 
take their own initiative, and at the same time reduce their ability to take care of 
themselves, significantly contributes to the patients’ low self-esteem. 
5. Children with congenital heart disease usually show poor school performance and 
they usually fall behind the progress of their healthy schoolmates owing to the fact 
that they have a long treatment process involving frequent hospital admissions and 
therefore, prolonged absence from school. 
6. Educational level of the parents is significantly influencing their children’s quality 
of life. The educational level of the parents is also associated with the absence or 
delay in seeking medical assistance, and thereby with the worsening of the children’s 
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health. Parents with a low educational and income level tend to have difficulties in 
recognizing that their children need advisory support, or they ignore its importance 
and its consequence. 
7. Maintenance of an overall good health including a balanced diet, prevention of 
anemia, and full vaccination against the common diseases is the factor that 
contributes positively to the improvement of the quality of life. Treatment of anemia 
is  importance, especially in patients with cyanosis, which improves physical 
performance, their general health condition, and therefore, their quality of life. 
 
2.7 CONCEPT OF HEALTH RELATED QUALITY OF LIFE (HRQOL) 
The concept of health related quality of life  and its determinants has evolved since 
the 1980s to encompass those aspects of overall quality of life that can be clearly 
shown to affect health either physical or mental (CDC, 2013). 
Health related quality of life reflects the patient’s perception of the impact of the 
illness and its treatment on their life (Nousi et al, 2010). 
HRQOL is defined as a multidimensional construct composed of the patient’s 
perception of the impact of disease and treatment on his or her functioning in a 
variety of aspects of life, including the physical, psychological, and social domains 
(Landolt, Buechel  & Latal, 2008). 
Health related quality of life instruments are tools used for measuring patient’s 
functioning and general well-being. However, they may not sufficiently assess 
important areas that are likely to be affected specifically by a specific disease or its 
treatments. On the other hand, specific instrument does not permit comparisons 
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across conditions and treatments and rarely capture every aspect of health related 
quality of life important to patients. Therefore, a combined approach of measuring 
patient’s general functioning and well-being and specific measurements may be the 
best option in many situations (Varni, 2002, 2004). 
Solans, Pane, Estrada, Serra‐Sutton, Berra, Herdman & Rajmil, (2008) have 
identified several  instruments that have been used to assess the quality of life of 
children and adolescents in a systematic review of papers  published between years 
2001 and 2005, which consist of 30 generics, and 64 specific-disease instruments. 
The generic measures instruments include: 
• WHOQOL BREF Questionnaires 
• SF-36 scale questionnaires 
• Child Health Questionnaire (CHQ) 
• PedsQLTM 4.0 Generic core Scale  
Numerous disease specific instruments that have been used to evaluate patient with 
congenital heart disease and the examples are listed below: 
• Pediatric Cardiac Quality of Life Inventory (PCQLI) 
• Congenital Health Adolescent & Teenage Questionnaire (CHAT) 
• Congenital Heart Disease Quality of Life Questionnaire (ConQOL)  
• PedsQLTM 3.0 Cardiac Module  
The generic measure questionnaires assess the general health status, which quantifies 
the overall functional status and well-being but does not assess functional limitations 
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attributable to a particular disease. In contrast, a disease-specific instruments 
measured patient health related quality of life symptom burden, functional 
limitations, relevant to a specific condition. Disease specific health related quality of 
life measures have recently being developed for patient with congenital heart disease 
and are still in the process of being tested and validated for the population of 
different culture and language.  
Studies that have used generic instruments  to explore the  quality of life in children 
with congenital heart disease include Silva, Vaz, Areias, Proenca, Viana & Areias, 
(2011) which used the WHOQOL-BREF questionnaire to evaluate the quality of life 
of adolescents and young adults with congenital heart disease. The study showed that 
patients with congenital heart disease had a better perception of quality of life than 
did the general population in the category of psychological, social relationship and 
environment scales. The WHOQOL-BREF instrument contains 26 questions, with 
the first 2 questions being general and the remaining 24 questions being divided into 
four different domains: physical, psychological, social relationships and the 
environment. 
Another study that used generic measure questionnaires is the study by Lane, Lip, & 
Millane, (2002) which used SF-36 health survey questionnaires to assess the quality 
of life in adults with congenital heart disease at one general hospital in Birmingham, 
United Kingdom. The Short Form 36 health survey or SF-36 had 36 questions that 
relate to eight health status scales including physical functioning, general health, 
mental health, limitation of activities, social activities, emotional problems, social 
functioning and bodily pain. They found the poorest quality of life among adults with 
inoperable cyanotic congenital heart disease. 
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Studies that have used disease specific questionnaires include McCrindle,  Williams, 
Mital, Clark, Russell, Klein & Eisenmann, (2007) that looked at the reliability of the 
Congenital Heart Adolescent or Teenage (CHAT) questionnaire in subject aged 10 to 
18 years old. The questionnaire was piloted, revised, and then applied to subjects 
with congenital heart disease attending the pediatric cardiology outpatient clinics in 
seven paediatric cardiac centres in the United States and Canada. The items and 
domains showed excellent Cronbach's alpha and construct validity. Unfortunately, 
the questionnaires  are self reported assessment and cover a limited age group (10 to 
18 years old). 
Macran, Birks, Parsons, Sloper, Hardman, Kind,  & Lewin,  (2006) used another 
cardiac disease specific questionnaire for measuring the quality of life, the 
Congenital Heart Disease Quality of Life Questionnaire (ConQOL). The study was a 
multicenter study involving 640 children from six pediatric cardiology centers in the 
United Kingdom. The instrument was developed to measure health related quality of 
life for children with congenital heart disease within the age of 8 to 16 years old. 
Two versions are available for the two different age range groups: the first, for 
children 8-11 years old, it includes the scales, symptoms, activities and relationships, 
and second, for teenagers 12-16 years old, which additionally include a scale on 
coping and control. However, this instrument only measured children but not parent 
proxy report. The instrument is also limited to  the age group from 8 to 16 years old.  
Marino, Shera, Wernovsky, Tomlinson, Aguirre, Gallagher, & Tong, (2008) 
conducted a study using the Pediatric Cardiac Quality of Life Inventory (PCQLI). 
The aimed of the study was to develop an inventory covering a wider age group 
children from 8 to 12 years old and adolescents aged 13 to 18 years old and versions 
for patients and parents (Proxy).  The questionnaires were designed to discriminate 
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the different types of congenital and acquired heart diseases. The results of this pilot 
study, conducted in three cardiac clinics with 655 pairs of parents and patients in 
United states, showed good content validity, good internal consistency and construct 
validity of the instrument, with a good correlation between the components that 
measure the impact of the disease and the psychosocial impact. This inventory 
covers both children and parent proxy report but it is limited to age group 8 to 18 
years old. 
The PedsQLTM 3.0 Cardiac Module is different in contexts of having self and proxy-
report as well as covering a wide age group from 2 to18 years old. Many studies in 
the world have used this instrument such as Uzark et al., 2008; Tahirovic, Begic, 
Nurkic, & Varni, 2010; Menteer, Beas, Chang, Reed & Gold, 2013.  
The original English version showed excellent Cronbach's alpha and intraclass 
correlation coefficient. Uzark et al. (2003) determine the feasibility, reliability and 
validity of PedsQLTM 3.0 cardiac module English version of Cincinnati Children’s 
Hospital Medical Centre, USA. This study showed good internal consistency 
reliability coefficient ranging from 0.72 to 0.96. 
Uzark et al. (2008) used the PedsQL 3.0 cardiac module to assess the quality of life 
in Children With Heart Disease in both children and parents. The result showed 
children with heart disease had the lower quality of life than healthy children across 
all age groups. Children with more severe heart disease had worse physical and 
psychosocial quality of life. 
Tahirovic et al. (2010) conducted  a study using the PedsQLTM 3.0 Cardiac Module 
in 114 parents of children and 96 children with congenital heart disease. They found 
that HRQOL was poorest in children with complex congenital heart disease.  
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The cardiac disease specific questionnaires has been applied in congenital heart 
disease as well as other types of heart disease such as in the study was undertaken by 
Menteer et al. (2012). They evaluate health related quality of life in heart failure and 
post heart transplant patients using PedsQLTM 3.0 Cardiac Module. This study 
examined mood and health related quality of life in children with HF and compared 
them cross-sectionally with those of healthy control subjects and heart transplant 
recipients with good heart function. They found that health related quality of life is 
impaired in heart failure and post heart transplanted patients. 
The PedsQLTM 3.0 cardiac module has been translated into various languages such as 
Hungarian, Brazilian, Swedish and Spanish languages. This translated PedsQLTM 3.0 
Cardiac Module had been used to assess health related quality of life in the cardiac 
patient. Berkes, Varni, Pataki, Kardos, Kemény & Mogyorosy. (2010) investigated 
the psychometric properties of the Hungarian version of the PedsQLTM Generic Core 
Scales and Cardiac Module, they found good reliability and validity of the Hungarian 
translation of the PedsQLTM 4.0 Generic Core Scales and the PedsQLTM 3.0 Cardiac 
Module in Hungarian children with heart disease with Cronbach’s Alpha exceeding 
0.7. 
PedsQLTM 3.0 Cardiac Module has also been translated in Brazilian version. 
Nascimento, Terreri, Hilario & Len. (2013) did a study regarding HRQOL of 
children with rheumatic heart diseases: reliability of the Brazilian version of the 
PedsQLTM 3.0 Cardiac Module. 
The values of Cronbach’s Alpha varied from 0.6 to 0.8 indicating good internal 
consistency and the intraclass correlation coefficient also reproducible with adequate 
0.76 to 0.94 among patient and 0.76 to 0.84 among parent/caregiver.  
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The reliability of the Swedish version of PedsQLTM 3.0 Cardiac Module was 
evaluated in a study involving Swedish children with congenital heart disease (Sand, 
Kljajic, & Sunnegardh, 2013). The result showed, Cronbach’s alpha values 0.7 for 
both child and proxy report. 
PedsQLTM 3.0 Cardiac Module Spanish version was also had been published by 
Gonzalez-Gil, Mendoza-Soto, Alonso-Lloret, Castro-Murga, Pose-Becerra & Martin-
Arribas, (2012). Even though it differs from the original version in some respects 
especially in school functioning and physical appearance, the internal consistency 
was shown to be higher than 0.7. 
In Malaysia, no study has been undertaken to evaluate health related quality of life 
using PedsQLTM 3.0 cardiac modules. Malay is the major ethnic group in Malaysia 
and the official language is bahasa melayu. Hence, it is important to develop a 
validated Malay version of PedsQLTM 3.0 Cardiac Module.  
The PedsQLTM 3.0 Cardiac Module was chosen because of  the many advantages that 
includes: 
1. It has been validated 
2. It is developmentally appropriate for our subjects 
3. It is disease specific 
4. It is includes both self and proxy-report and covering a wider age group for 
children 5-18 years old and parent-proxy age 2-18 years old  
5. It can be conducted within 15 minutes  
6. The questionnaires are multidimensional, including heart problem and 
treatment, treatment II, perceived physical appearance, treatment anxiety, 
cognitive problem and communication  
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7. These questionnaires also had minimal missing data  
 
2.8 PedsQLTM 3.0 CARDIAC MODULE 
The PedsQL instrument was designed to measure health related quality of life in 
children with specific disorders. This enhances measurement sensitivity of health 
domains relevant to the specific disorders. In contrast, a generic health related quality 
of life instruments, measures the overall functional health status and well being of 
the patient and enable comparison of the chronic health condition with healthy 
populations (Varni, Seid, & Kurtin, 2001). 
The PedsQLTM 3.0 Cardiac Module was designed specifically to measure HRQOL in 
the pediatric population with congenital heart disease. This module has a more 
sensitive scaling range and additional construct and items, which are specific to 
cardiac patients compare to the generic core module. The PedsQLTM 3.0 Cardiac 
Module comprised of six domains, including heart problem, treatment, treatment 
anxiety, cognitive problems, perceived physical appearance and communication.  
 
2.9 CHILD SELF-REPORT VERSUS PARENT PROXY-REPORT 
The self-report  HRQOL is considered  the gold standard in the adult. However, in 
pediatric populations, the accuracy of  self-report is affected by several factors 
including cognitive function, language skills and developmental stage (Varni, Seid & 
Rode, 1999; Cremeens, Eiser & Blades, 2006). Pediatric HRQOL instruments must 
take into account the child’s cognitive function and developmental stage. They also 
need to look at the perspective of the parental-proxy report.  
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The parental proxy-report of HRQOL is used to estimate child HRQOL when the 
child is unable or unwilling to complete the HRQOL measure such as when the child 
is too young, cognitively impaired, and ill or fatigued to complete the instrument. 
This parent proxy report is also used when young child self-report scale reliabilities 
< 70 standards (Varni et al., 2002, 2007c).  
Information provided by proxy-reports is not in complete agreement with patient’s 
report (Varni et al., 1999; Cremeens et al, 2006). This imperfect agreement between 
self-report and proxy-report, is also known as cross-informant variance. Parents’ 
proxy-report instruments need to be used in patients who are unable to self-report 
such as toddlers (age 2 to 4 years), ill patients, cognitively impaired and those who 
are unable to provide self-report. The demonstration of cross-informant variance 
using previous tools indicates the need for a more reliable and valid child self-report 
HRQOL measurement instrument for the broadest age range possible (Varni et al, 
1999, 2002).  
The previous study has shown that pediatric patients as young as 5 years old can 
reliably and validly self-report their HRQOL when an age-appropriate measurement 
instrument is utilized (Varni et al, 2007a, 2007b). Pediatric patient-reported 
outcomes should be accepted as the standard for HRQOL measurement in pediatric 
clinical trials.  
Consequently, a reliable and valid parent proxy-report instrument are essential when 
children themselves are unable to self-report. Parent proxy-report should only be the 
primary outcome measure when the child is too young or ill or otherwise unable to 
self-report (Varni et al, 2007c). Even though pediatric patient self-report is preferred; 
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there remains a fundamental role for parent proxy-report in pediatric clinical trials 
and health services research. 
 
2.10 RATIONALE OF THE STUDY 
Up to date, there is no assessment tool in Bahasa Melayu to measure HRQOL among 
children with heart disease. The validated tool is available is in English and other 
languages. Therefore, it is important to produce a translated Malay version 
PedsQLTM 3.0 Cardiac Module that could be used for the population in Kelantan and 
Malaysia. 
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3. OBJECTIVES 
3.1   GENERAL OBJECTIVE 
• To produce a reliable and validated Malay version PedsQLTM 3.0 Cardiac 
Module. 
3.2 SPECIFIC OBJECTIVES 
i. To translate PedsQLTM 3.0 Cardiac Module questionnaires from English 
version to Malay version. 
ii. To assess the reliability of PedsQLTM 3.0 Cardiac Module Malay version. 
iii. To assess the validity of PedsQLTM 3.0 Cardiac Module Malay version. 
 
3.3  HYPOTHESIS 
• The Malay version of PedsQLTM 3.0 cardiac module is reliable and valid tool 
for assessing HRQOL in children with congenital heart disease in the 
Kelantanese population. 
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4. METHODOLOGY 
4.1 RESEARCH DESIGN 
This is a cross sectional study. The study was conducted at Hospital Universiti Sains 
Malaysia (HUSM) and Hospital Raja Perempuan Zainab II (HRPZ II), Kota Bharu 
Kelantan. 
 
4.2 PARTICIPANTS 
The participants were divided into 2 groups: 
1. Children with congenital heart disease aged between 5-18 years old.  
2. Parents or guardians of children diagnosed with congenital heart disease aged 
between 2-18 years old.  
Children with Congenital Heart Disease were identified from admission registrations 
in Hospital Universiti Sains Malaysia (HUSM) and Hospital Raja Perempuan Zainab 
II (HRPZ II). The participants were recruited when they came for follow up in the 
cardiac and echocardiography clinic. 
 
4.2.1 INCLUSION CRITERIA 
1. Patients with congenital heart disease 
2. Age of patients from 2-18 years old  
3. Parents and guardians of children with congenital heart disease age 2-18 years 
old 
